Revolut's mark is being rewritten this week: on July 22, 2026 the company confirmed a secondary share sale underway at $2,017 per share — an implied ~$115B, more than 50% above November 2025's $75B and roughly 2.5× August 2024's $45B. Unlike most private-market melt-ups, the fundamentals underneath are audited and violent: FY2025 revenue of $6.0B (+46% on a GBP basis), $2.3B of pre-tax profit at a 38% margin — a fifth consecutive profitable year — 75M+ customers, $67.5B of customer balances, and $1.7T of transaction volume. The licence walls that capped the story for half a decade fell in sequence: the UK full banking licence in March 2026 after a five-year saga, a US national bank charter application filed with the OCC and FDIC the same month, Mexico live in January, and Australia's first-ever fintech ADI launched July 21. No S-1 exists; Storonsky says the IPO is "two years away" (~2028) with investors briefed on a $150–200B internal target and a Nasdaq preference. The debate isn't whether the business is real — it's whether a mark compounding faster than 46% revenue growth leaves anything on the table for the roadshow.
| Metric | Value |
|---|---|
| Founded | 2015 · Nik Storonsky & Vlad Yatsenko |
| HQ | London (Canary Wharf global HQ) · Paris Western-Europe HQ opening early 2027 |
| CEO | Nik Storonsky · CFO Victor Stinga |
| Completed Marks | $33B Series E (Jul 2021) → $45B secondary (Aug 2024) → $75B secondary (Nov 2025) — Coatue, Greenoaks, Dragoneer, Fidelity; NVIDIA's NVentures & a16z participating |
| Live Mark | ~$115B implied · secondary at $2,017/share confirmed underway Jul 22, 2026 (not yet closed) |
| FY2024 → FY2025 Revenue | $4.0B → $6.0B (£4.5B, +46% GBP basis) |
| Profitability | $2.3B pre-tax profit · 38% margin · net profit $1.7B · fifth consecutive profitable year |
| Customers | 75M+ (Jul 2026) · 68.3M retail + 767K business at end-2025 · 13M in the UK |
| Balances / Volume | $67.5B customer balances (+66%) · $1.7T transaction volume (+65%) |
| Banking Licences | UK (full, Mar 2026) · EEA (Lithuania) · Mexico (Jan 2026) · Australia ADI (Jul 21, 2026) · US OCC/FDIC charter filed Mar 2026 |
| Headcount | 12,200 (end-2025) · >⅓ in financial crime roles |
| IPO Status | No S-1 · Storonsky (Apr 2026): "two years away" → ~2028 · $150–200B internal target · Nasdaq preference |
Revolut started in 2015 with a single wedge — an FX travel card that killed foreign-exchange fees — and spent a decade layering everything else a current account touches on top: payments, subscriptions, savings, stocks and ETFs, crypto, credit, business banking, even eSIM mobile plans. The strategic difference versus every Western neobank peer: Revolut refused to stay a payments app. It ground through banking licences in 30+ markets — accepting a five-year UK regulatory saga as the cost — because deposits fund lending, and lending is where neobank economics graduate into bank economics. It reports in GBP (the USD figures above are the company's own illustrative conversions), grows by word-of-mouth (63% of new retail customers arrive via referral or organically), and now claims one in five working-age adults in Europe as customers.
| Line | FY2025 Revenue | Strategic Role |
|---|---|---|
| Card payments | $1.3B · +45% | The transactional core — interchange scales with 75M users |
| Interest income | $1.3B · +23% | $67.5B of balances, 90% parked in cash & Treasuries — the licence dividend |
| Subscriptions | $936M · +67% | Paid plans +42% YoY — the recurring-revenue layer public markets pay up for |
| Wealth | $876M · +31% | Stocks, ETF plans (EEA + CH), CFDs in 29 countries, crypto + Revolut X exchange |
| FX | $800M · +43% | The original wedge — still compounding |
| Revolut Business | 16% of income (£708M) | 767K businesses, 30K joining monthly, >140% growth in SG/AU/US |
| Lending | $2.9B book · +120% | Personal loans, cards, nascent mortgages (Lithuania live) — the licence payoff |
| Mobile + RevPoints | — | eSIM plans in UK/Poland; 17M RevPoints users in 36 markets — engagement lock-in |
The moat thesis rests on four pillars:
Revolut's revenue path is hyper-growth with a profitability twist almost no scaled neobank has printed: $1.1B (2022) → $2.2B (2023) → $4.0B (2024) → $6.0B (2025, +46% GBP basis), with pre-tax profit accelerating faster than revenue — $1.4B (2024) → $2.3B (2025, +57%) for a 38% pre-tax margin, up from 35%. Net profit reached $1.7B. That's the fifth consecutive profitable year, achieved while entering new markets at a pace (40+ live, 30 more targeted by 2030) that would normally shred margins.
The mix shift is the story public-market analysts will model: subscriptions grew 67% to $936M — recurring software-style revenue inside a bank — while interest income (+23% to $1.3B) is the slowest-growing large line, meaning Revolut is becoming less rate-dependent as it scales. Business banking is already 16% of income. Lending — the highest-margin destiny of those $67.5B in balances — is still only a $2.9B book, which is the growth optionality the UK, Mexican, and Australian licences just unlocked. Gross margin runs at 78%, and the fraud-and-compliance machine (a third of all headcount, AI review at 10× former case volume) is the operating cost that scales sub-linearly from here.
Revolut has not filed, and for once the timeline isn't speculation: at the IMF Spring Meetings in April 2026, Storonsky told David Rubenstein an IPO is "two years away" — pointing at roughly 2028 — adding that "public companies are trusted more compared to private companies." Per FT reporting, investors have been briefed on an internal listing target of $150–200B, with a long-signalled preference for a US venue, most likely Nasdaq (a political sore point in London, where no 2026 commitment exists). The company runs employee-and-early-investor secondaries every one to two years instead of rushing the float — August 2024 at $45B, November 2025 at $75B, and now the July 2026 sale underway at $2,017 per share (~$115B implied), first reported by Bloomberg and confirmed to Reuters by the company, targeting at least $750M of shares per June reporting.
The July 22 confirmation that shares are clearing at $2,017 (~$115B) makes Revolut one of the world's most valuable private companies and rewrites the IPO math in real time: at $115B the company is priced near ~19× trailing revenue — versus ~12.5× at the November $75B round and ~11× at the 2024 tender.
Base case: secondaries close, the US charter decision lands within a year of the March 2026 filing, and the S-1 follows in 2027–28. The catalysts to watch: OCC/FDIC approval, any confidential-filing report, and whether FY2026 holds the ~46% growth that underwrites the target band.
| Company | Status | Positioning vs Revolut |
|---|---|---|
| Nubank (NU) | Public | The scale comp — 100M+ LatAm customers; traded below its 2021 listing price for over a year before re-rating: the cautionary precedent for pricing |
| Chime (CHYM) | Public (Jun 2025) | US neobank comp — deposit-and-interchange model without Revolut's product breadth or licences |
| SoFi (SOFI) | Public | Proof the US bank-charter path re-rates a fintech — the playbook Revolut's OCC filing follows |
| Wise (WISE.L) | Public | FX/cross-border rails specialist — the original wedge competitor, not a super-app |
| Monzo | Private | The UK rival — 13M+ customers and its own full UK licence, but largely single-market |
| N26 / Starling | Private | European neobanks that pulled back from global ambitions Revolut kept funding |
| JPMorgan Chase (Chase UK), incumbents | Public | Deep-pocketed retail-bank flankers; compete on trust and deposits, not product velocity |
Revolut's position is unusual: it is simultaneously the largest Western neobank by customers, the broadest by product surface, and — since March — a fully licensed bank in its home market. Monzo matches it on UK licence status but not on geography; Nubank matches it on scale but is LatAm-centric; Wise matches the FX core but abandoned the super-app fight. The competitor that matters for the IPO narrative is really the public-market comp set itself: Revolut will ask to be valued as a growth-software-plus-bank hybrid, and the gap between Nubank-style bank multiples and the ~19× the live secondary implies is exactly the battleground the roadshow will fight on.
Beyond the compounding core, three bets carry the $150–200B ambition:
None of these needs to work for the $6B core to keep compounding — but the internal IPO target effectively prices at least the first two. That's the difference from the value-name setups in this pipeline: here the options are in the mark, not free.
| Mark | Implied Value | vs Revenue | Context |
|---|---|---|---|
| Series E · Jul 2021 | $33B | ~35×+ (then <$1B) | ZIRP-era pricing — long since grown into |
| Secondary · Aug 2024 | $45B | ~11× FY2024 | Coatue-led tender; the post-licence-limbo reset |
| Secondary · Nov 2025 | $75B | ~12.5× FY2025 | Completed — Coatue, Greenoaks, Dragoneer, Fidelity; NVentures & a16z in |
| Secondary · Jul 2026 | ~$115B (underway) | ~19× trailing | $2,017/share per Reuters/Bloomberg · not yet closed |
| IPO target (per FT) | $150–200B | ~17–22× 2027E* | *If ~40%+ growth holds through 2027 — the entire debate |
| Nubank (NU) | — | ~mid-single-digit × | The scale comp's bank-style multiple — the bear anchor |
The frame cuts both ways. Bull: a 46%-growth, 38%-pre-tax-margin business (a "rule of 84" print) with five profitable years, hard licences, and $67.5B of deposits deserves software-hybrid pricing, and the crossover investors buying at $75B and again near $115B are the same institutions that will anchor the book. Bear: Nubank — bigger by customers, similar model, LatAm growth — spent a year underwater after listing at growth-stock multiples, and Revolut's interest-income line (its co-largest) is rate-cycle exposed. The honest read: at ~$115B the private market has already paid for flawless execution through 2027, including the US charter. The $150–200B target requires the roadshow to price Revolut as a category of one — which, on the licence-breadth evidence, is at least an argument rather than a fantasy.
| Risk | Severity | Mitigant |
|---|---|---|
| Fraud & complaints record | High | Worst UK firm for APP-fraud complaints to the Ombudsman in 2024 (3,242 cases; Which?/FOS data) — but >⅓ of staff work financial crime, AI review 10×'d case throughput, and >£600M of fraud was blocked in 2024 |
| US charter approval | High | Fintech-to-bank conversions face intense scrutiny and the UK precedent took 5 years — but four full licences (UK, EEA, MX, AU) now evidence regulator acceptance |
| Mark ahead of fundamentals | Medium–High | ~19× trailing on an in-progress secondary; Nubank's post-IPO year underwater is the precedent — the completed $75B is the hard floor reference |
| Rate sensitivity of interest income | Medium | $1.3B line grew just 23% — but subscriptions (+67%) and payments (+45%) are diluting rate dependence each year |
| Founder concentration / governance | Medium | FT-reported incentive package could take Storonsky toward ~40% ownership at a $200B valuation — a proxy-advisor flashpoint (reported, not company-confirmed) |
| Regulatory sprawl | Medium | 40+ markets, 30+ licences, ECB among supervisors — compounding compliance surface as it scales |
| Competition (Monzo UK, incumbents, LatAm expansion) | Low–Medium | Breadth + licence set unmatched; word-of-mouth CAC keeps the growth engine cheap |
| Route | How | Caveats |
|---|---|---|
| Private secondary marketplaces | Revolut shares via secondary platforms | Accredited only · pricing near the live $2,017/share mark · transfer consent applies |
| Crossover funds | Fidelity, T. Rowe Price, Franklin Templeton vehicles hold it | Diversified, indirect |
| NU / CHYM | Public neobank beta | Different geographies; the multiple anchors Revolut must out-argue |
| SOFI | The US-charter re-rating playbook | US-only; a read-through on Revolut's charter catalyst |
| WISE.L | The FX-rails pure play | Wedge competitor, not a super-app comp |
| Patience | Wait for the S-1 (~2028 per the CEO) | Cleanest entry — but management is targeting $150–200B, so the discount may already be spent |
Revolut is the momentum franchise of the pre-IPO pipeline — the mirror image of the flat-mark value setups. The fundamentals are genuinely elite: $6B revenue growing 46%, a 38% pre-tax margin, five straight profitable years, 75M+ customers, and a licence lattice (UK, EEA, Mexico, Australia, US pending) that no fintech on earth can match. The question was never the business; it's the clock and the multiple. A secondary clearing near $115B this week — up 53% in eight months — means private buyers have already paid roughly 19× trailing revenue, pricing in the US charter, the lending flywheel, and another year of flawless execution before any prospectus exists. With Storonsky signposting 2028 and a $150–200B internal target, the pipeline's usual asymmetry is inverted: the roadshow here is likelier to ratify the private mark than to gift an entry below it. For IPO-watchlist purposes the catalysts are concrete — the OCC/FDIC decision, the close of the live secondary, FY2026 growth holding above ~40% — and the discipline is equally concrete: respect the completed $75B as the last hard mark, treat $115B as the market's bet, and let Nubank's first public year stay taped to the monitor as the reminder of what happens when a great neobank meets a full price.